Remove 2008 Remove Diabetes Remove Vaccines
article thumbnail

Prevalence of Dosage Modifications and Impact on Response Milestone Among Patients With CML Treated With Imatinib Using RWD

Pharmacy Times

Eligible patients include adults (≥ 18 years) diagnosed with CML receiving imatinib as first-line therapy for more than 1 month between 2008 and 2023. Materials and Methods This retrospective observational study utilized the Carolina Data Warehouse for Health electronic health record (EHR) database.

article thumbnail

132 patient safety experts to know | 2025

Beckers Hospital Review

Under his guidance, Penn Medicine continues to achieve national recognition for its pioneering research, including CAR T cell therapy and Nobel Prize-winning mRNA vaccine technology. His work also includes advancing health equity through chronic disease management, resulting in the elimination of racial disparities in diabetes control.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

57 hospital and health system CXOs to know | 2025

Beckers Hospital Review

Cohen has been the chief experience officer at the University Medical Center of Southern Nevada since 2008. During her tenure, Dr. Pankow has overseen vaccine governance, led the expansion of team-based care, helmed the HonorHealth medical group social determinants of health initiative, and implemented a diabetes prevention program.

article thumbnail

Top 20 RNAi Therapeutic Companies Based on 2022 R&D Expenditure

PharmaShots

Founded Year: 2008 Total Employees: ~2110 Headquarters: Dublin, Ireland Market Cap: $1.7M Stock Exchange: NYSE Novo Nordisk is a global healthcare biopharma company focusing on its mission to drive change and fight against diabetes and other serious chronic diseases such as obesity, rare blood, and rare endocrine diseases.

article thumbnail

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2003-2022)

PharmaShots

In 2008, Johnson acquired tissue sealing system developer, SurgRx Pfizer's pharmaceutical segment revenue increased after the acquisitions of Serenex, Encysive Pharmaceuticals, CovX, and Coley Pharmaceuticals Novartis reported a total revenue of $41.4B, under which, its pharmaceutical division faced a revenue loss of $2.6B

article thumbnail

Top 20 IPOs in Healthcare by Total Fund Value

PharmaShots

Founded Year: 2008 No. The Company's premier line of smart safety syringes, Sharps Provensa, prevents accidental needlestick injuries, prevents needle reuse, and minimizes drug and vaccine waste—all while maintaining the intuitive simplicity of conventional syringes. In Sep’22 stakeholders exercised 0.7M of Shares: 2.1M

article thumbnail

World Standards Day: Recognizing How Standards Enable a Strong Medicines Supply Chain

Quality Matters

By enabling a multi-manufacturer environment, USP standards have helped increase the availability of medicines to treat cardiovascular disease, cancer, diabetes, mental health and many other conditions. Since manufacturers know the precise quality specifications, standards help make the approval process for generic medicines more efficient.